Where does Iridex Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Iridex Corporation ranks #8,415 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Iridex Corporation hold?

Iridex Corporation holds 38 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Iridex Corporation's Innovation Score?

Iridex Corporation has an Innovation Score of 41.0 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Iridex Corporation's patent grant rate increasing or decreasing?

Iridex Corporation's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Iridex Corporation's patents?

Iridex Corporation's patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Iridex Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Iridex Corporation

Q: What technology areas does Iridex Corporation focus on?

Iridex Corporation's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 35 patents, ranking #180 of 3,082 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 38 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Iridex ranks #8,415 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 11 technology areas.

#8,415
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 20.6
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8415 · US Corporation #8,415 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,415/49,997
PHOTO-FINISH Hinkley Lighting
CPC-FOCUS A61F · 11 areas
INNOV-PAR 41.0/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hinkley Lighting, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Iridex’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (31%) Velocity 4.3 pts (10%) Breadth 11.7 pts (28%) Claim depth 12.4 pts (30%)

Qualcomm Incorporated · highest

85
BHS Corrugated… · near

41
CSR Technology… · near

41
Gamesa Innovation &… · near

41
Iridex · this assignee

41
Vieworks · near

41
3D Lighting… · lowest

7

What this shows Iridex's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Iridex?

Each dot is one of Iridex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Iridex’s own 20.6 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Iridex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Iridex's grants concentrate

Iridex Corporation is a focused PatentsView assignee: 11 CPC subclasses with 92.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2018. By volume, Iridex sits between Hinkley Lighting, Inc. and InterMetro Industries Corporation.

Iridex's three-year grant acceleration

Iridex Corporation shows 9 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hinkley Lighting

38
Indium

38
Innowireless

38
Ipla Holdings

38
Idenix Pharmaceut…

38
Ikanos Communicat…

38
Intelmate

38
Intermetro Indust…

38
Iridex ◀

38

What this shows Iridex holds 38 patents at rank #8,410, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Iridex

By rank, the assignees closest to #8,410 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Iridex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Iridex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Iridex ranks #180 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Vieworks Co., Ltd. 41 BHS Corrugated Maschinen-und Anlagenbau GMBH 41 Gamesa Innovation & Technology, S. L. 41 CSR Technology Holdings Inc. 41

Iridex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Iridex Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.9%
2016	4	10.5%
2017	3	7.9%
2018	1	2.6%
2019	6	15.8%
2020	2	5.3%
2021	6	15.8%
2022	3	7.9%
2023	4	10.5%
2024	2	5.3%
2025partial year	4	10.5%

Which technologies does Iridex Corporation patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 35

A61B - DIAGNOSIS; SURGERY; Identification 27

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 9

G02B - Optical Elements, Systems OR Apparatus 6

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 3

G03B - Apparatus OR Arrangements FOR Taking Photographs OR FOR Projecting OR Viewing THEM; Apparatus OR Arrangements Employing Analogous Techniques Using Waves Other Than Optical WAVES; Accessories Therefor 2

H04N - Pictorial Communication, e.g. Television 2

Y10T - Technical Subjects Covered BY Former US Classification 2

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Iridex Corporation's patent record in context - here's where to go next.

Iridex Corporation's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 92.1% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #8,415 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Iridex Corporation against Hinkley Lighting, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.